0001562180-23-006838.txt : 20230913
0001562180-23-006838.hdr.sgml : 20230913
20230913160228
ACCESSION NUMBER: 0001562180-23-006838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230911
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Agresta Samuel
CENTRAL INDEX KEY: 0001748961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 231252667
MAIL ADDRESS:
STREET 1: 784 MEMORIAL DR.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-09-11
true
0001822462
Foghorn Therapeutics Inc.
FHTX
0001748961
Agresta Samuel
500 TECHNOLOGY SQUARE
STE 700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Medical Officer
false
Stock Options (Right to buy)
16.63
2031-01-27
Common Stock
100000.00
100000.00
D
Stock Options (Right to buy)
14.87
2032-01-25
Common Stock
125000.00
125000.00
D
Stock Options (Right to buy)
8.77
2030-08-17
Common Stock
91891.00
91891.00
D
Stock Options (Right to buy)
8.38
2033-01-25
Common Stock
60000.00
60000.00
D
The option vested as to 25% of the underlying shares of common stock on January 28, 2022, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter.
The option vested as to 25% of the underlying shares of common stock on January 26, 2023, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter.
The option vested as to 25% of the underlying shares of common stock on August 17, 2021, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter.
The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
Exit Form 4 filed solely to report the Reporting Person is no longer an officer of the Issuer within the meaning of Rule 16a-1 of the Securities Exchange Act of 1934, as amended.
/s /Allan Reine, M.D., Attorney-in-Fact
2023-09-13